Study of a treatment for upper stomach bleeding
Part of Digestive system clinical trials.
This trial tests a medication to help stop bleeding in the upper part of the stomach and esophagus. It may offer a new option for people with this urgent condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently having bleeding in the upper stomach or esophagus.
- You are able to give consent for treatment.
- You are not pregnant at the time of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well a risk score predicts the need for treatment in patients with upper gastrointestinal bleeding (bleeding in the stomach or esophagus). It may help doctors decide if you need urgent care.
This trial studies a procedure called endoscopic treatment to stop bleeding in the upper digestive tract. It may help stop active bleeding and reduce the chance of bleeding again.
This trial tests whether a medicine called trimebutine maleate helps doctors see the stomach lining more clearly during an emergency endoscopy for upper GI bleeding. If it works, it could help doctors find and treat the bleeding more easily.
This study tests a new blue dye spray (UI-EWD) versus standard endoscopy treatment for people with active upper GI bleeding. The goal is to see if the dye helps doctors find and stop bleeding more effectively.
This trial tests a new ingestible capsule called PillSense that can detect bleeding in the upper part of your digestive system. If you come to the emergency room with signs of upper GI bleeding (like vomiting coffee-ground material or having black stools) but without obvious black stool on a physical exam, this study will see if the capsule works as well as the usual endoscopy procedure.
This trial studies whether a newer “OTSC” procedure works as well as a standard procedure called angiographic embolization to stop active, hard-to-control upper gastrointestinal bleeding. It may help people whose bleeding continues or comes back even after initial endoscopy treatment.
Hear when a new Upper Gastrointestinal Bleeding (UGIB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.